News US regulator grants $23 million to rare disease R&D FDA announces 21 rare disease clinical trial research grants.
News EU regulator recommends Intercept's potential liver blockbus... Sales forecast to reach $2.6 billion in 2020.
News Alnylam plunges after deaths in rare disease trial Biotech axes revusiran due to safety concerns.
News Faron moves ahead with "shock lung" drug Finnish firm eyes first drug for acute respiratory distress syndrome.
News US and EU regulators collaborate on rare diseases Clinical trial design among areas regulators will collaborate on
News Zafgen ends development of Prader-Willi drug Share price plummets after biotech said drug is unsafe.
News BridgeBio poised to challenge Pfizer after Attruby approval BridgeBio grabs FDA approval for its ATTR cardiomyopathy drug Attruby, setting up a challenge to market leader Pfizer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
